Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Clinical trial NCT04211168 · UNKNOWN
Trial details
- NCT number
- NCT04211168
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2024-07-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.